PMO June 2014

Page 1

Unifying Oncologists & Pathologists

A Peer-Reviewed Journal June 2014 • Volume 3 • Number 4

PM O

BIOMARKERS • TARGETED THERAPIES • DIAGNOSTICS

Personalized Medicine in Oncology TM

IMMUNO-ONCOLOGY Immuno-Oncology Takes Center Stage at ASCO 2014...............................................Page 198

THE BIOMARKER Molecular Diversity of CLL..............................Page 202

INTERVIEW WITH THE INNOVATORS Implementing Global Healthcare: Partners In Health and the Rwandan Cancer Center Initiative. An Interview With Lawrence N. Shulman, MD, of Dana-Farber Cancer Institute.......................Page 206

PROSTATE CANCER Androgen Suppression in Castration-Resistant Prostate Cancer.................................................Page 212

VALUE-BASED CANCER CARE Personalizing Value-Based Medicine...........Page 220

THE LAST WORD PMO and the PMC – A Collaboration to Advance Precision Medicine. Introducing Dr Edward Abrahams, President of PMC, as the Author of The Last Word....................Page 238

GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™

The official publication of

GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™

WORLD CUTANEOUS MALIGNANCIES CONGRESS

© 2014 Green Hill Healthcare Communications, LLC An affiliation of The Lynx Group

WORLD CUTANEOUS

In partnership with


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.